Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin for male pattern baldness
RBR-5z2rr58Completed
- Sponsor
- Faculdade de Ciências Médicas - UERJ
- Start
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Triple-blind, single-arm trial of botulinum toxin type A in androgenetic alopecia (AGA), sponsored by Faculdade de Ciências Médicas - UERJ. Started Jan 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on RBR-5z2rr58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5z2rr58.